Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
HRCT1
REST API REST API
Homo sapiens
HRCT1 is differentially expressed in 102 experiments: 49 organism parts: mammary gland, adipose tissue, ... (47 more);, 38 disease states: normal, glioblastoma, ... (36 more);, 27 cell types 195 cell lines 11 compound treatments and 45 other conditions.
Synonyms UNQ338, LGLL338, PRO537
Orthologs Hrct1 (Mus musculus)   LOC100359865 (Rattus norvegicus)   (Compare orthologs)
Gene Ontology Term membrane, integral to membrane
UniProt Accession Q6UXD1
Search EB-eye ENSG00000196196
Show more properties
Experimental Factors
Organism part

studied in E-MTAB-37, E-GEOD-6573, E-GEOD-18105, E-AFMX-6, E-GEOD-7307, ... (8 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-3860, E-GEOD-17482, E-GEOD-19639, E-GEOD-24147, E-MEXP-903, ... (19 experiments)

Factor Value U/D Experiments
MCF-7
3
E-GEOD-5823, E-GEOD-20081, E-GEOD-19639
UT-15
1
E-GEOD-17347
NB4
1
E-GEOD-12662
SUDHL10
1
E-MTAB-37
MKN45
1
E-GEOD-15460
DU-145
1
E-MEXP-2172
189 more value(s).


Cell type

studied in E-GEOD-13987, E-GEOD-18811, E-MEXP-2360, E-GEOD-12662, E-GEOD-20033, ... (10 experiments)

Factor Value U/D Experiments
squamous cell carcinoma
1
E-GEOD-17347
parental foreskin cells
1
E-GEOD-20033
memory B cell
1
E-TABM-702
mesenchymal stem cell
1
E-GEOD-9894
naive B cell
1
E-TABM-702
adult native RPE from 78 y.o. donor
1
E-GEOD-18811
21 more value(s).


Disease state

studied in E-GEOD-3307, E-MEXP-1922, E-GEOD-19743, E-GEOD-3744, E-GEOD-15960, ... (21 experiments)

Factor Value U/D Experiments
glioblastoma
2
E-MTAB-37, E-GEOD-4290
FKRP mutation
1
E-GEOD-3307
engineered invasive esophageal squamous cell carcinoma
1
E-GEOD-21293
acute myeloid leukemia
1
E-MTAB-37
NDV
1
E-GEOD-18791
pancreatic carcinoma
1
E-MTAB-37
32 more value(s).


Compound treatment

studied in E-GEOD-3284, E-GEOD-15205, E-GEOD-6400, E-MEXP-2241, E-GEOD-7307, ... (6 experiments)

Factor Value U/D Experiments
unknown
1
E-GEOD-7307
TGF
1
E-GEOD-15205
bacterial endotoxin
1
1
E-GEOD-3284
ethanol
1
E-MEXP-2241
not specified
1
E-GEOD-20081
actinomycin D
1
E-GEOD-6400
5 more value(s).


Age at diagnosis

studied in E-GEOD-3494

Factor Value U/D Experiments
77
1
E-GEOD-3494
28
1
1
E-GEOD-3494


Agent
studied in E-GEOD-19519

Biosource provider
studied in E-TABM-325, E-MTAB-37

BioSourceProvider
studied in E-GEOD-19519

Cancer site
studied in E-GEOD-4271

Clinical history
studied in E-GEOD-19420, E-TABM-234, E-GEOD-19743, E-GEOD-7967, E-GEOD-21589, ... (6 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-21589, E-GEOD-16363, E-GEOD-18995, ... (6 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-20033

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-GEOD-22544, E-GEOD-19665

Estrogen receptor status
studied in E-GEOD-6532

Family relationship
studied in E-MEXP-1425

Genetic modification
studied in E-MTAB-73, E-GEOD-20847

Genotype
studied in E-GEOD-3494, E-GEOD-17347

Growth condition
studied in E-GEOD-13073, E-MEXP-2657, E-GEOD-20504, E-GEOD-9764, E-GEOD-10315, ... (6 experiments)

Histology
studied in E-TABM-234, E-TABM-276

Individual
studied in E-MTAB-197, E-TABM-325, E-MEXP-2069, E-TABM-666, E-MEXP-2128, ... (17 experiments)

Infection
studied in E-MEXP-561

Injury
studied in E-GEOD-19743

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-GEOD-9171

Media
studied in E-MEXP-765

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

organ
studied in E-GEOD-24283

Organism
studied in E-TABM-84

Organism status
studied in E-GEOD-19188

P53 ihc
studied in E-GEOD-21653

Phenotype
studied in E-GEOD-17636

Population
studied in E-GEOD-4922

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532

Protocol type
studied in E-GEOD-19246

Rna integrity
studied in E-TABM-325

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-21374, E-GEOD-17400, E-GEOD-18995

Stimulation
studied in E-GEOD-20114, E-GEOD-11428

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

Tissue
studied in E-GEOD-30573

Treatment
studied in E-GEOD-19246, E-GEOD-13818

Tumor grading
studied in E-GEOD-4290, E-GEOD-4922

Tumor size
studied in E-GEOD-3494

Processing time: 0.582 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM